Literature DB >> 16904842

Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions.

Ruiguo Liu1, John M Buatti, Terese L Howes, John Dill, Joseph M Modrick, Sanford L Meeks.   

Abstract

PURPOSE: The aim of this study was to determine the optimal number of coplanar and noncoplanar external beams in the setting of stereotactic body radiotherapy (SBRT). METHODS AND MATERIALS: Spherical targets were delineated within 2 separate extracranial sites, the lung and liver, with diameters varying from 2 cm to 7 cm to cover the range of volumes used in SBRT. Treatment plans were created for all target volumes using 5 to 15 geometrically optimized coplanar and noncoplanar conformal beams. Dose gradient and normal tissue complication probability (NTCP) were evaluated for each set of beam configurations and for each target size.
RESULTS: For all lung and liver target volumes, the dose gradient improved with an increase in beam number from 5 to 15 for both coplanar and noncoplanar beam configurations. NTCP decreased as the beam number increased from 5 to 9 beams for all target sizes for both coplanar and noncoplanar beams. There is no significant improvement in NTCP when more than 9 beams were used for treatment planning regardless of target size.
CONCLUSION: Based on dosimetric criteria, the optimal number of external beams is 13 to 15 for SBRT using either coplanar or noncoplanar beam bouquets. Simple biologic models indicate that the optimal number of beams is 9 for SBRT of lung and liver lesions >2 cm, whereas smaller lesions may benefit from plans using up to 13 beams.

Entities:  

Mesh:

Year:  2006        PMID: 16904842     DOI: 10.1016/j.ijrobp.2006.05.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Investigation of the effects of treatment planning variables in small animal radiotherapy dose distributions.

Authors:  Amy R Motomura; Magdalena Bazalova; Hu Zhou; Paul J Keall; Edward E Graves
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

Review 2.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

3.  Tradeoffs for assuming rigid target motion in Mlc-based real time target tracking radiotherapy: a dosimetric and radiobiological analysis.

Authors:  T Roland; C Shi; Y Liu; R Crownover; P Mavroidis; N Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2010-04

4.  Stereotactic body radiotherapy for stage I non-small cell lung cancer.

Authors:  Ben J Slotman
Journal:  J Radiosurg SBRT       Date:  2011

Review 5.  Current status of stereotactic body radiotherapy for lung cancer.

Authors:  Yasushi Nagata; Yukinori Matsuo; Kenji Takayama; Yoshiki Norihisa; Takashi Mizowaki; Michihide Mitsumori; Keiko Shibuya; Shinsuke Yano; Yuichiroh Narita; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2007-02-25       Impact factor: 3.402

Review 6.  Treatment of metastatic liver tumors using stereotactic ablative radiotherapy.

Authors:  Vimoj J Nair; Jason R Pantarotto
Journal:  World J Radiol       Date:  2014-02-28

7.  Beam's-eye-view imaging during non-coplanar lung SBRT.

Authors:  Stephen S F Yip; Joerg Rottmann; Ross I Berbeco
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

8.  A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT.

Authors:  W C Wu; C L Chan; Y W Wong; J P Cuijpers
Journal:  Br J Radiol       Date:  2009-09-01       Impact factor: 3.039

9.  Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting.

Authors:  Zhao-Chong Zeng; Jinsil Seong; Sang Min Yoon; Jason Chia-Hsien Cheng; Ka-On Lam; Ann-Shing Lee; Ada Law; Jian-Ying Zhang; Yong Hu
Journal:  Liver Cancer       Date:  2017-08-30       Impact factor: 11.740

10.  Comparison of simple and complex liver intensity modulated radiotherapy.

Authors:  Mark T Lee; Thomas G Purdie; Cynthia L Eccles; Michael B Sharpe; Laura A Dawson
Journal:  Radiat Oncol       Date:  2010-11-30       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.